Thermo Fisher Scientific Eyes Qiagen

Posted on 11/14/2019


Waltham, Massachusetts-based Thermo Fisher Scientific Inc. is considering a takeover of Qiagen NV, a molecular testing firm. As of recent trading data, Qiagen has a market value of US$ 8.3 billion. Private equity firm Cinven and Abu Dhabi Investment Authority (ADIA) appears to be interested in Qiagen as well.

In 2017, Thermo Fisher made a US$ 5 billion takeover of drug-ingredient maker Patheon NV. In 2014, the Thermo Fisher spent US$ 15 billion purchase of Life Technologies Corporation.